2023 Session

Budget Amendments - SB800 (Member Request)

View Budget Item
View Budget Item amendments

Chief Patron: Bell
Prescription of Schedule VI Controlled Substances

Item 301 #1s

Item 301 #1s

First Year - FY2023 Second Year - FY2024
Health and Human Resources
Department of Health Professions FY2023 $0 FY2024 $50,000 GF

Page 353, line 18, strike "$38,667,396" and insert "$38,717,396".


(This amendment provides $50,000 the second year from the general fund related to legislation in the 2023 Session directing the Board of Pharmacy to conduct a review of Schedule VI controlled substances and report to the Chairs of the Senate Committee on Education and Health and the House Committee on Health, Welfare and Institutions by December 31, 2023, any Schedule VI substances that the General Assembly may want to consider rescheduling due to potential risk of abuse by a patient if prescribed in accordance with the standard of care for asynchronous telemedicine interactions.)